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INTRODUCTION
Anisakis and Pseudoterranova are the 2 nematode genera that 
are most frequently associated with human anisakidosis. Any 
fish or cephalopod species can be parasitized by the 3rd stages 
of these larvae. The ingestion of the 3rd stage larvae can also 
induce anisakidosis in humans [1]. Symptoms of anisakidosis 
arise when the nematode penetrates the gastric mucosa, which 
results in acute epigastric pain, occasionally accompanied by 
nausea and vomiting. Another common manifestation of hu-
man anisakidosis is an IgE-mediated immune reaction that 
sometimes occurs in sensitized individuals. Anisakis has been 
implicated in a range of allergic diseases, including dermatitis, 
asthma, and food allergy [2-4]. It has been estimated that 7% 
to 36% of seafood processing workers develop occupational 
asthma, while 3% to 11% have urticaria and atopic or protein 
contact dermatitis [5]. In fact, as many as 15% of adult asthma 
cases are related to occupational exposure [2].
Live larvae can also cause gastrointestinal diseases in humans. 
However, whether direct exposure to Anisakis antigens can di-
rectly lead to systemic allergic sensitization is yet to be demon-
strated [2]. Sensitization to Anisakis may occur via ingestion of 
infected fish, inhalation of airborne Anisakis allergens or direct 
contact with Anisakis proteins in fish [6]. Therefore, some aller-
gens might directly lead to systemic allergic responses. As A. 
simplex allergens, the following 12 protein types have been iden-
tified to date; secretory gland protein (Ani s 1) [7], myosin (Ani 
s 2, 3) [8,9], protease inhibitors (Ani s 4, 6) [10,11], the SXP/
RAL-2 family proteins (Ani s 5, 8, 9) [11-13], and proteins with 
repetitive sequences (Ani s 7,10-12) [14-16]. In addition to 
these identified allergens, there might be many other unknown 
allergens. 
In a previous study, we identified the As22U protein from 
the 3rd stage larvae of Anisakis simplex [17]. The function of this 
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Abstract: We have reported that a 24 kDa protein (22U homologous; As22U) of Anisakis simplex larvae could elicit sever-
al Th2-related chemokine gene expressions in the intestinal epithelial cell line which means that As22U may play a role as 
an allergen. In order to determine the contribution of As22U to allergic reactions, we treated mice with 6 times intra-nasal 
application of recombinant As22U (rAs22U). In the group challenged with rAs22U and ovalbumin (OVA), the number of 
eosinophils in the bronchial alveolar lavage fluid (BALF) was significantly increased, as compared to the group receiving 
only OVA. In addition, mice treated with rAs22U and OVA showed significantly increased airway hyperresponsiveness. 
Thus, severe inflammation around the airway and immune cell recruitment was observed in mice treated with rAs22U 
plus OVA. The levels of IL-4, IL-5, and IL-13 cytokines in the BALF increased significantly after treatment with rAs22U and 
OVA. Similarly, the levels of anti-OVA specific IgE and IgG1 increased in mice treated with rAs22U and OVA, compared to 
those treated only with OVA. The Gro-α (CXCL1) gene expression in mouse lung epithelial cells increased instantly after 
treatment with rAs22U, and allergy-specific chemokines eotaxin (CCL11) and thymus-and-activation-regulated-chemo-
kine (CCL17) gene expressions significantly increased at 6 hr after treatment. In conclusion, rAs22U may induce airway 
allergic inflammation, as the result of enhanced Th2 and Th17 responses. 
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protein is not exactly known, but it may influence the host, 
because it was found in the group of excretory-secretory (ES) 
proteins [17]. In addition, we found that they could elicit Th2-
related chemokine gene expression in the intestinal epithelial 
cells. However, we did not evaluate its allergenic activity in vivo 
animal model. Experimental respiratory allergens are distin-
guished by their ability to elicit allergic lung inflammation 
when inhaled. Ovalbumin (OVA) is a commonly used experi-
mental allergen, incapable of eliciting allergic inflammations 
if administered strictly by means of inhalation, whereas pollen 
and fungal-derived allergens readily induce allergic responses 
when administered through the respiratory tract [18-20]. There-
fore, if As22U has allergen properties, repeated administration 
through the respiratory tract could elicit allergic airway inflam-
mation. 
In this study, in order to investigate whether As22U has al-
lergic properties, we constructed recombinant As22U (rAs22U) 
and administrated it to the mouse respiratory system. Our find-
ings confirmed that, by repeated administrations, rAs22U in-
duces eosinophilic inflammation in the lung, in part by coor-
dinating the production of both chemokines and cytokines 
necessary for the recruitment of eosinophils. 
MATERIALS AND METHODS
Generation of rAs22U protein using the pET28a 
expression vector
Following confirmation of the PCR product sequences, the 
As22U clone was extracted for ligation into a pET28a expres-
sion vector system (Novagen, Darmstadt, Germany). Thereaf-
ter, ligates were transformed into E. coli strain BL21. After de-
termining the optimal expression conditions, large-scale cell 
cultures were prepared via re-inoculation of overnight cultures 
of E. coli BL21 in 1 L of fresh lactose broth medium, contain-
ing 100 µg/ml of ampicillin, at a dilution factor of 1:100. The 
cells were cultured to an OD of 0.8-1.0 at A600 for approxima-
tely 8 hr, with vigorous agitation at 25˚C. Induction of fusion 
protein expression was followed by the addition of isopropyl 
β-D-1-thiogalactopyranoside, at a final concentration of 0.1 
mM. The rAs22U protein was purified using the HisTrap
TM HP 
column (Amersham Biosciences, Little Calfont, UK). LPS was 
depleted from the rAs22U (i.e. endotoxin levels <0.01 μg/ml), 
using the Detoxi-Gel Affinity Pak prepacked columns (Amer-
sham Biosciences), in accordance with the manufacturer’s in-
structions.
Induction of the airway inflammatory reaction
Female C57BL/6 mice at the age of 5 weeks were purchased 
from Samtako Co. (Gyeonggi-do, Korea). The mice were bred 
in a SPF facility, at the Institute for Laboratory Animals of Pu-
san National University. Chicken egg OVA (Sigma, Seoul, Ko-
rea) was reconstituted in sterile PBS, at 1 mg/ml, and stored at 
-20˚C. For intranasal challenge, 10 μl (10 μg) of rAs22U was 
added to 40 μl (40 μg) of OVA, immediately before intranasal 
administration. C57BL/6 mice were exposed to airway inflam-
mation for 6 total challenges, as previously described [20-22]. 
One day after the last challenge, the lung function (i.e., airway 
hyperresponsiveness level) was evaluated, and then mice were 
sacrificed for analysis of the bronchial alveolar lavage fluid 
(BALF). 
Airway hyperresponsiveness measurements
The enhanced pause (PenH), a measure of bronchial con-
striction, was evaluated at baseline and after treatment with in-
creasing doses of aerosolized methacholine (i.e., 2.5-50 mg/
ml), via whole-body plethysmography for animals (Allmedi-
cus, Korea). In the plethysmography procedure, the mice were 
allowed to acclimate for 3 min, exposed to nebulized saline 
for 4 min, then subsequently treated with increasing concen-
trations (0, 2.5, 5, 10, and 50 mg/ml) of nebulized methacho-
line (Sigma) in saline, using an ultrasonic nebulizer. After each 
nebulization, recordings were obtained for 3 min, and the PenH 
values measured during each 3 min period were averaged. Gra-
phs of the PenH values, in response to the increasing metha-
choline concentrations, were constructed for each dose-match-
ed group of mice.
Analysis of BALF
BALF was isolated from mice after scarification with 200 μl 
of ketamine: lumpun: PBS (2:3:5) solution. The chest cavity 
was exposed to allow for expansion, then the trachea was care-
fully intubated and the catheter was secured with ligatures. Pre-
warmed PBS was slowly inflated into the lungs and withdrawn. 
The collected BALF was then centrifuged, and the supernatants 
were maintained at -70˚C, until used for ELISA. The cell pellets 
were resuspended and washed twice in PBS. After RBC lysis us-
ing the ACK lysis buffer (Invitrogen, Carlsbad, California, USA), 
the total number of cells was counted using a hemocytometer. 
The BALF cell smears were prepared with the Cytospin appara-
tus. The smears were then stained with Diff-Quik solution (Da-
de Diagnostics of Puerto Rico. Inc., Aguada, Puerto Rico) in   Park et al.: A 24 kDa protein of Anisakis eliciting allergic inflammation   375
tative of at least 2 independent experiments performed with at 
least 4 mice in each group, unless otherwise indicated. Data 
were analyzed using the Student’s t-test (n=2 groups). A 5% 
or lower P-value was considered to be statistically significant.
RESULTS 
rAs22U could elicit airway allergic inflammation
To investigate the role of rAs22U as an allergen, we repeat-
edly applied rAs22U with OVA at increasing doses into the 
nose of mice and evaluated the allergic responses elicited in 
the lung. After 6 times challenges of rAs22U with OVA, we 
found evident immune cell infiltrations, particularly eosino-
phils, into the lung (Fig. 1A). In addition, we noted infiltration 
of inflammatory cells in the pulmonary parenchyma of the 
mice (Fig. 1B). These influxes of inflammatory cells induced 
severe inflammation and pulmonary edema of the alveolar 
wall. Both bronchial epithelial cell and goblet cell hyperplasia 
were observed in the lung of mice treated with rAs22U and 
OVA. In order to determine whether the lung inflammation 
induced by rAs22U was associated with alterations in the lung 
function, variations in intra-tracheal pressure in response to 
increasing methacholine doses were evaluated. The values of 
Penh after methacholine administration (dose ranging from 
2.5 mg/ml to 50 mg/ml) increaed significantly in the mouse 
group treated with rAs22U and OVA, as compared with the 
mice treated only with OVA (Fig. 1C). 
rAs22U elevated Th2 and Th17 productions in the lung
In order to determine the manner in which rAs22U could 
influence cytokine secretion in BALF, ELISA was performed to 
detect IL-4, IL-5, IL-13, and IL-17A cytokine levels. Concentra-
order to determine the cell differentials, in accordance with 
conventional morphologic criteria. 
Lung histopathology
Histological analyses were conducted, as described previ-
ously [23]. In brief, the lung tissues were fixed with formalde-
hyde and embedded in paraffin. The thin sections of the em-
bedding tissues were then stained with hematoxylin-eosin stain. 
After staining, we microscopically examined the stained sec-
tions.
ELISA
Anti-As22U specific immunoglobulins (IgG1, IgG2a, and 
IgE) in serum and cytokine interleukin levels (IL-4, IL-5, IL-13, 
and IL-17A) in BALF were determined via ELISA. All of these 
were conducted in accordance with the manufacturer’s instruc-
tions (ebioscience, San Diego, California, USA). The absorban-
ce of the final reactant was determined using an ELISA plate 
reader set at 450 nm. 
The lung epithelial cell culture and rAs22U treatment
A mouse lung epithelial cell line (MLE12) was purchased 
from American Type Culture Collection. The cells were main-
tained in Dulbecco’s Modified Eagle’s Medium (Hyclone, Road 
Logan, Utah, USA) supplemented with 10% heat-inactivated 
FBS (Hyclone), 2 mM L-glutamine, 100 units/ml of penicillin, 
and 100 µg/ml of streptomycin. The cells were then cultured at 
37˚C, in a humidified atmosphere containing 5% CO2. For rA-
s22U treatment (final concentration 1 µg/ml) the cells were 
plated in 10 cm plates at 1×10
6 cells/well and incubated for 
the indicated time periods. After 2 hr stimulation, cells were 
collected and lysed, and the total RNA was extracted using the 
QIAzol reagent (Qiagen Science, Valencia, California, USA). 
RT-PCR analysis 
Total RNA was generated to cDNA using moloney murine 
leukemia virus reverse transcriptase (Promega, Madison, Wis-
consin, USA). For quantitation of both cytokine and transcrip-
tion factor gene expression, cDNA samples were amplified in 
the iQ SYBR Green Supermix (Bio-Rad Laboratories Inc., Her-
cules, California, USA). The primer pairs used for RT-PCR are 
shown in Table 1.
Statistics
Results are represented as the mean±SD. Data are represen-
Table 1. Primers used for real-time PCR
Primers Sequence
GAPDH*-for
† 5´-TACCCCCAATGTGTCCGTC-3´
GAPDH-rev
‡ 5´-AAGAGTGGGAGTTGCTGTTGAAG-3´
Eotaxin-for 5´-GCGCTTCTATTCCTGCTGCTCACGG-3´
Eotaxin-rev 5´-GTGGCATCCTGGACCCACTTCTTC-3´
TARC
§-for 5´-AGAGCTGCTCGAGCCACCAATGTA-3´
TARC-rev 5´-CACCAATCTGATGGCCTTCTTCAC-3´
Gro-α-for 5´-CGCTTCTCTGTGCAGCGCTGCTGCT-3´
Gro-α-rev 5´-AAGCCTCGCGACCATTCTTGAGTG-3´
IL-25-for 5´-TGGCAATGATCGTGGGAACC-3´
IL-25-rev 5´-GAGAGATGGCCCTGCTGTTGA-3´
*GAPDH, Glyceraldehyde-3-phosphate dehydrogenase; 
†for, forward; 
‡rev,  reverse; 
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tions of these cytokine increased significantly in the BALF of 
rAs22U treated mice (Fig. 2). These findings show that rAs22U 
could elicit allergic airway reactions, via activating Th17 and 
Th2 cytokines. Additionally, rAs22U elicited a significant in-
crease in the OVA-specific IgE and IgG1 serum levels, although 
the production of OVA-specific IgG2a remained unaffected 
(Fig. 3). These results showed that rAs22U could increase im-
mune response allergen-specific antibody production. 
rAs22U activated CXCL1 and allergy specific genes 
expression.
In order to investigate the mechanisms of both Th2 and Th17 
elevation by As22U, we evaluated several cytokine and chemo-
kine gene expression levels in the MLE12 after rAs22U treat-
ment. The results demonstrated that Gro-α (CXCL1) gene ex-
pression levels increased at 2 hr after As22U treatment. After 6 
hr, thymus-and-activation-regulated-chemokine (TARC, CCL17) 
and eotaxin (CCL11) gene expression reached the highest lev-
els. Although IL-25 gene expression increased significantly at 2 
hr after rAs22U treatment, the increase was smaller than for 
other genes (Fig. 4).
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Fig. 2. Cytokine levels in BALF. The level of IL-4, IL-5, IL-13, and     
IL-17A in BALF were determined using sandwich ELISA. Levels 
of all cytokines were significantly increased after rAs22U treat-
ment. The data for cytokine levels in the BALF are expressed as 
means ±SD of values from individual mice (**, P<0.01; ***, P< 
0.001).
7.5
5.0
2.5
0.0
N
o
.
 
o
f
 
d
i
f
f
e
r
e
n
t
 
c
e
l
l
s
 
(
 
×
1
0
6
)
Total
Macrophage
Eosinophils
Neutrophils
Lymphocytes
OVA
OVA+As22U
**
**
*
A 
OVA OVA+As22U
B
12.5
10.0
7.5
5.0
2.5
0.0
P
e
n
H
  0.0  12.5  25.0  37.5  50.0
Dose of methylcholine (mg/ml)
OVA
OVA+As22U
**
*
C
Fig. 1. Induction of eosinophilic airway inflammation after rAs22U 
treatment. (A) The differential immune cells were counted in BALF. 
The number of immune cells, especially eosinophils and lym-
phocytes were increased in BALF of mice treated with rAs22U. 
(B) A thin section of the lung stained with hematoxylin-eosin 
(Bar=50 μm, ×100). In the lungs of mice treated with rAs22U, 
massive peribronchial infiltration with immune cells and hyperp-
lasis of bronchial epithelial cells were observed. Also, thickened 
bronchial epithelial cells were observed in rAs22U-treated mice. 
(C) Enhanced pause (PenH) was increased at baseline and after 
treatment with increasing doses of aerosolized methacholine (0 
to 50 mg/ml). The PenH value of rAs22U-treated mice was sig-
nificantly higher than that of the only OVA-treated mice (*, P< 
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DISCUSSION
Recently, much interest has focused on the relationship be-
tween helminth infections and atopic diseases by many re-
searchers. This interest is mainly because these 2 disorders share 
immunological features, such as the dominant Th2 type of im-
mune responses, which is characterized by increased serum 
IgE and eosinophilia [24]. Remarkably, certain helminth infec-
tions have been reported to suppress [25-27], while others to 
contribute to the development of allergic manifestations [2,3, 
28,29]. Most parasites that involved in allergic inflammations 
were larval stage nematodes, especially roundworms in several 
Fig. 3. The level of OVA-specific immunoglobulin in serum. OVA-specific IgE, IgG1, and IgG2a levels in serum were measured. The   
96-well plates were incubated with OVA (final concentration 10 μg/ml) for 16 hr at 4°C. After blocking with 1% BSA, sera ere diluted 
with PBS to 1:10
4-10
6 for IgG1 and IgG2a measurement, and the levels of immunoglobulins were measured. The rAs22U treated mice 
had significantly increased serum levels of OVA-specific IgE and IgG1 (**, P<0.01; ***, P<0.001).
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Fig. 4. Chemokine gene expression in mouse lung epithelial cells after rAs22U treatment. After treatment with 10 μg/ml (final concen-
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mammals. Roundworms have been found to infect most mam-
mals, and also exhibit host specificity. The majority of round-
worms generally show a visceral larva migration period during 
their life cycle, which is essential for their development into 
adult worms. Many case reports have demonstrated that round-
worm larvae can cause asthma, pneumonia, and airway infla-
mmation [30-32]. In addition, parasite-derived protein could 
elicit allergic responses [33-35]. 
In our study, we evaluated the possibility of As22U to act as 
an allergen, using the new allergic mouse model. As results, re-
peated treatments with rAs22U could elicit strong airway in-
flammation, with high eosinophilia and IgE levels in experi-
mental mice (Figs. 1, 3). In addition, we found significantly 
increased IL-4 and IL-5 cytokine levels in BALF (Fig. 2). It is 
well known that several Th2 cytokines, such as IL-4, IL-5, IL-9, 
and IL-13, induced by Anisakis infection and also play impor-
tant roles in development of airway hyperreactivity [36]. Espe-
cially IL-4 regulates the isotype class switching in B cells to IgE 
synthesis, and IL-5 stimulates the eosinophil growth, activates 
these cells, and prolongs the eosinophil survival [37]. Eosino-
phils and IgE proved vitally important in the allergy-induced 
Th2 respon  ses, and also in increasing the number of these cells. 
The increased serum levels of IgE were specific responses to 
parasite infections and this response was shown to be elicited 
only by treatment with parasite total proteins [38,39]. 
Interestingly, we also found that the IL-17A cytokine level in 
BALF was significantly increased (Fig. 2). In addition, rAs22U 
treatment could activate CXCL1 gene expression in the mouse 
lung epithelial cell (Fig. 4). These results showed that rAs22U 
could elicit allergic airway inflammation via both Th17 and 
Th2 cell activations. In our previous study, repeated treatments 
with the excretory-secretory protein extracted from A. simplex 
could elicit neutrophil recruitment and IL-17A production, 
which might play a critical role in the Anisakis-associated aller-
gic reaction [33]. IL-17A and IL-17F cytokines are members of 
the IL-17 family, playing central roles in allergic inflamma-
tions. Recent studies have reported that IL-17A and IL-17F cy-
tokine production from a distinct Th lymphocyte subset (i.e. 
Th17) was specifically induced by IL-23, which was generated 
by both dendritic cells and macrophages, in response to mi-
crobial sti  muli. The IL-23/IL-17 axis may therefore constitute a 
link between infections and allergic diseases [40-42]. In addi-
tion, IL-17A, IL-17F, and IL-23 cytokines have been shown to 
induce the release of chemokines Gro-α (CXCL1), IL-8 (CXCL8), 
and MIP-1beta (CCL4) from eosinophils [42]. Shainheit et al. 
[43] previously reported that schistosome egg-stimulated den-
dritic cells plus naive CD4 T-cells from CBA mice resulted in 
increa  sed levels of pre-inflammatory cytokines, as well as IL-
17, and the chemokines CXCL1, CXCL2, and CCL2. They 
demonstrated that after neutralization of IL-23 and IL-1, but 
not of IL-6 or IL-21, egg-induced IL-17A production was pro-
foundly inhibited. They also emphasized that parasite recogni-
tion, followed by a genetically determined innate proinflam-
matory response, induces the development of Th17 cells, and 
thus controls the outcome of immunopathology in schistoso-
miasis [43]. 
We evaluated alteration of allergy-specific chemokine gene 
(i.e. TARC and eotaxin) expressions by rAs22U treatment, and 
found that the gene expressions were significantly increased 
after the treatment (Fig. 4). Th2 cells preferentially express sev-
eral receptors, such as CCR3 (receptor of eotaxin, CCL13, and 
CCL28), CCR4 (receptor of TARC and MDC), and CCR8 (re-
ceptor of CCL1), and the chemokines active on these receptors 
are increased in allergic inflammation, making them attractive 
candidates to mediate Th2 cell-specific recruitment [44,45]. Ei-
ther inhibition or deletion of single chemokines or chemokine 
receptors (e.g., eotaxin, MDC, TARC) have not abolished the 
Th2 cell recruitment in allergic pulmonary inflammations [44]. 
Therefore, rAs22U might elicit Th2 cell recruitment via eleva-
tion of both eotaxin and TARC secretion levels in the lung epi-
thelial cell. In conclusion, rAs22U may induce allergic airway 
inflammation as the result of enhanced Th2 and Th17 responses. 
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